TCL Archive EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor. December 15, 2000
TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997